Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
CeQur
230
CeQur
Technology
Biotechnology
Health Care
Medical
Medical Devices
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Suggest edits
Founded
2008
Raised
$156.6M
Follow us
Companies in the same industry
IsoPlexis
Apama Medical
EIT Emerging Implant Technologies GmbH
NanoCellect Biomedical
AxioMed, LLC
CortiCare
Thrive Earlier Detection
Arch Therapeutics
XACT Robotics
Illumina
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$100,000,000
Venture capital (Series C) - 2015
Endeavour Vision
Woodford Investment Management
VI Partners
+2
$27,000,000
Venture capital (Series B) - 2013
Team Size
50+
Employees
I work here
Location
Switzerland
Headquarters
Explore Switzerland
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when CeQur makes some noise.
